This independent HPLC lab test confirms Cagrilintide/Semaglutide 10mg blend from KÖLD at 99.38% purity. The analysis was conducted by Accumark Labs on March 4, 2026. Individual components tested at Cagrilintide 5.21mg (99.19% purity) and Semaglutide 5.55mg (99.56% purity).
Cagrilintide and Semaglutide are GLP-1 receptor agonists researched for their role in metabolic regulation and weight management. A blend purity level of 99.38% indicates minimal contamination and high-grade synthesis.
The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.